To include your compound in the COVID-19 Resource Center, submit it here.

RUNX1, RUNX3, CBFB and PMP22 as targets for neurofibromatosis

DISEASE CATEGORY: Cancer

INDICATION: Neurofibromatosis

Cell culture and mouse studies suggest promoting PMP22 expression, dual RUNX1/RUNX3 inhibition,

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE